Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Barnes

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|August 1, 1997
Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literatureH Stanley-Christian, B K Heim, J F Hines, et al.
Gynecologic Oncology|December 1, 1992
Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancerA F Burnett, W A Barnes, J C Johnson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1994
The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodiesJ F Hines, S J Ghim, N D Christensen, et al.
Gynecologic Oncology|October 1, 1994
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccinationJ F Hines, S J Ghim, N D Christensen, et al.
Gynecologic Oncology|May 1, 1991
Identification of human papillomavirus type 16 in primary and recurrent cervical cancer following radiation therapyR W Holloway, M P Farrell, C Castellano, et al.
Gynecologic Oncology|January 1, 1994
Insertion of Groshong central venous catheters utilizing fluoroscopic techniquesA F Burnett, S V Lossef, K H Barth, et al.
Gynecologic Oncology|March 1, 1991
Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestineJ F Barter, D Marlow, R K Kamath, et al.
Gynecologic Oncology|March 31, 2000
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervixJ V Lacey, L A Brinton, W A Barnes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reactionP E Gravitt, J V Lacey, L A Brinton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|August 1, 1997
Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literatureH Stanley-Christian, B K Heim, J F Hines, et al.
Gynecologic Oncology|December 1, 1992
Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancerA F Burnett, W A Barnes, J C Johnson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1994
The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodiesJ F Hines, S J Ghim, N D Christensen, et al.
Gynecologic Oncology|October 1, 1994
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccinationJ F Hines, S J Ghim, N D Christensen, et al.
Gynecologic Oncology|May 1, 1991
Identification of human papillomavirus type 16 in primary and recurrent cervical cancer following radiation therapyR W Holloway, M P Farrell, C Castellano, et al.
Gynecologic Oncology|January 1, 1994
Insertion of Groshong central venous catheters utilizing fluoroscopic techniquesA F Burnett, S V Lossef, K H Barth, et al.
Gynecologic Oncology|March 1, 1991
Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestineJ F Barter, D Marlow, R K Kamath, et al.
Gynecologic Oncology|March 31, 2000
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervixJ V Lacey, L A Brinton, W A Barnes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reactionP E Gravitt, J V Lacey, L A Brinton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Pageof 4